Cargando…
VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling
BACKGROUND: Although ongoing development of therapeutic strategies contributes to the improvements in clinical management, clear cell renal cell carcinoma (ccRCC) deaths originate mainly from radiochemoresistant and metastatic disease. Transcription factor SALL4 has been implicated in tumorigenesis...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278163/ https://www.ncbi.nlm.nih.gov/pubmed/32513235 http://dx.doi.org/10.1186/s13046-020-01609-8 |
_version_ | 1783543278126235648 |
---|---|
author | Sun, Jinbo Tang, Qisheng Gao, Yongheng Zhang, Wei Zhao, Zhining Yang, Fan Hu, Xiangnan Zhang, Dan Wang, Yong Zhang, Huizhong Song, Bin Zhang, Bo Wang, He |
author_facet | Sun, Jinbo Tang, Qisheng Gao, Yongheng Zhang, Wei Zhao, Zhining Yang, Fan Hu, Xiangnan Zhang, Dan Wang, Yong Zhang, Huizhong Song, Bin Zhang, Bo Wang, He |
author_sort | Sun, Jinbo |
collection | PubMed |
description | BACKGROUND: Although ongoing development of therapeutic strategies contributes to the improvements in clinical management, clear cell renal cell carcinoma (ccRCC) deaths originate mainly from radiochemoresistant and metastatic disease. Transcription factor SALL4 has been implicated in tumorigenesis and metastasis of multiple cancers. However, it is not known whether SALL4 is involved in the pathogenesis of ccRCC. METHODS: Analyses of clinical specimen and publicly available datasets were performed to determine the expression level and clinical significance of SALL4 in ccRCC. The influence of SALL4 expression on ccRCC tumor growth, metastasis and vascularity was evaluated through a series of in vitro and in vivo experiments. Western blotting, immunofluorescence staining and integrative database analysis were carried out to investigate the underlying mechanism for SALL4-mediated oncogenic activities in ccRCC. RESULTS: SALL4 expression was increased in ccRCC and positively correlated with tumor progression and poor prognosis. SALL4 could promote ccRCC cell proliferation, colony formation, cell cycle progression, migration, invasion and tumorigenicity and inhibit cell senescence. Further investigation revealed a widespread association of SALL4 with individual gene transcription and the involvement of SALL4 in endothelium development and vasculogenesis. In the context of ccRCC, SALL4 promoted tumor vascularization by recruiting endothelial cells. In addition, we found that SALL4 could exert its tumor-promoting effect via modulating Akt/GSK-3β axis and VEGFA expression. VHL mutation and DNA hypomethylation may be involved in the upregulation of SALL4 in ccRCC. CONCLUSIONS: Overall, our results provide evidence that upregulated SALL4 can function as a crucial regulator of tumor pathogenesis and progression in ccRCC, thus offering potential therapeutic strategies for future treatment. |
format | Online Article Text |
id | pubmed-7278163 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-72781632020-06-09 VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling Sun, Jinbo Tang, Qisheng Gao, Yongheng Zhang, Wei Zhao, Zhining Yang, Fan Hu, Xiangnan Zhang, Dan Wang, Yong Zhang, Huizhong Song, Bin Zhang, Bo Wang, He J Exp Clin Cancer Res Research BACKGROUND: Although ongoing development of therapeutic strategies contributes to the improvements in clinical management, clear cell renal cell carcinoma (ccRCC) deaths originate mainly from radiochemoresistant and metastatic disease. Transcription factor SALL4 has been implicated in tumorigenesis and metastasis of multiple cancers. However, it is not known whether SALL4 is involved in the pathogenesis of ccRCC. METHODS: Analyses of clinical specimen and publicly available datasets were performed to determine the expression level and clinical significance of SALL4 in ccRCC. The influence of SALL4 expression on ccRCC tumor growth, metastasis and vascularity was evaluated through a series of in vitro and in vivo experiments. Western blotting, immunofluorescence staining and integrative database analysis were carried out to investigate the underlying mechanism for SALL4-mediated oncogenic activities in ccRCC. RESULTS: SALL4 expression was increased in ccRCC and positively correlated with tumor progression and poor prognosis. SALL4 could promote ccRCC cell proliferation, colony formation, cell cycle progression, migration, invasion and tumorigenicity and inhibit cell senescence. Further investigation revealed a widespread association of SALL4 with individual gene transcription and the involvement of SALL4 in endothelium development and vasculogenesis. In the context of ccRCC, SALL4 promoted tumor vascularization by recruiting endothelial cells. In addition, we found that SALL4 could exert its tumor-promoting effect via modulating Akt/GSK-3β axis and VEGFA expression. VHL mutation and DNA hypomethylation may be involved in the upregulation of SALL4 in ccRCC. CONCLUSIONS: Overall, our results provide evidence that upregulated SALL4 can function as a crucial regulator of tumor pathogenesis and progression in ccRCC, thus offering potential therapeutic strategies for future treatment. BioMed Central 2020-06-08 /pmc/articles/PMC7278163/ /pubmed/32513235 http://dx.doi.org/10.1186/s13046-020-01609-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Sun, Jinbo Tang, Qisheng Gao, Yongheng Zhang, Wei Zhao, Zhining Yang, Fan Hu, Xiangnan Zhang, Dan Wang, Yong Zhang, Huizhong Song, Bin Zhang, Bo Wang, He VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling |
title | VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling |
title_full | VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling |
title_fullStr | VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling |
title_full_unstemmed | VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling |
title_short | VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling |
title_sort | vhl mutation-mediated sall4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via akt/gsk-3β signaling |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278163/ https://www.ncbi.nlm.nih.gov/pubmed/32513235 http://dx.doi.org/10.1186/s13046-020-01609-8 |
work_keys_str_mv | AT sunjinbo vhlmutationmediatedsall4overexpressionpromotestumorigenesisandvascularizationofclearcellrenalcellcarcinomaviaaktgsk3bsignaling AT tangqisheng vhlmutationmediatedsall4overexpressionpromotestumorigenesisandvascularizationofclearcellrenalcellcarcinomaviaaktgsk3bsignaling AT gaoyongheng vhlmutationmediatedsall4overexpressionpromotestumorigenesisandvascularizationofclearcellrenalcellcarcinomaviaaktgsk3bsignaling AT zhangwei vhlmutationmediatedsall4overexpressionpromotestumorigenesisandvascularizationofclearcellrenalcellcarcinomaviaaktgsk3bsignaling AT zhaozhining vhlmutationmediatedsall4overexpressionpromotestumorigenesisandvascularizationofclearcellrenalcellcarcinomaviaaktgsk3bsignaling AT yangfan vhlmutationmediatedsall4overexpressionpromotestumorigenesisandvascularizationofclearcellrenalcellcarcinomaviaaktgsk3bsignaling AT huxiangnan vhlmutationmediatedsall4overexpressionpromotestumorigenesisandvascularizationofclearcellrenalcellcarcinomaviaaktgsk3bsignaling AT zhangdan vhlmutationmediatedsall4overexpressionpromotestumorigenesisandvascularizationofclearcellrenalcellcarcinomaviaaktgsk3bsignaling AT wangyong vhlmutationmediatedsall4overexpressionpromotestumorigenesisandvascularizationofclearcellrenalcellcarcinomaviaaktgsk3bsignaling AT zhanghuizhong vhlmutationmediatedsall4overexpressionpromotestumorigenesisandvascularizationofclearcellrenalcellcarcinomaviaaktgsk3bsignaling AT songbin vhlmutationmediatedsall4overexpressionpromotestumorigenesisandvascularizationofclearcellrenalcellcarcinomaviaaktgsk3bsignaling AT zhangbo vhlmutationmediatedsall4overexpressionpromotestumorigenesisandvascularizationofclearcellrenalcellcarcinomaviaaktgsk3bsignaling AT wanghe vhlmutationmediatedsall4overexpressionpromotestumorigenesisandvascularizationofclearcellrenalcellcarcinomaviaaktgsk3bsignaling |